Status:
ACTIVE_NOT_RECRUITING
M-Suubi: A Multi-Level Integrated Intervention to Reduce the Impact of HIV Stigma
Lead Sponsor:
Washington University School of Medicine
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
HIV/AIDS
Eligibility:
All Genders
10-17 years
Phase:
NA
Brief Summary
M-Suubi, a three arm cluster randomized study will examine the effects and cost-effectiveness of a multi-level intervention on HIV viral suppression among 840 adolescents living with HIV (ALHIV) enrol...
Detailed Description
HIV stigma remains a formidable barrier to HIV treatment adherence among adolescents in Uganda, contributing to low rates of medication adherence and viral suppression (less than 50%) and high attriti...
Eligibility Criteria
Inclusion
- HIV-positive adolescents confirmed by medical report
- Prescribed antiretroviral therapy
- Enrolled in primary and secondary schools in a boarding section
- Caregivers of ALHIV who agree to participate in the study
- Teachers, school nurses, and administrators in the target schools who agree to participate in the study
Exclusion
- \- A significant cognitive impairment that interferes with the participant's understanding of the informed consent process, or inability/unwillingness to commit to completing the study
Key Trial Info
Start Date :
March 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2026
Estimated Enrollment :
1851 Patients enrolled
Trial Details
Trial ID
NCT05307250
Start Date
March 15 2022
End Date
July 31 2026
Last Update
August 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
International Center for Child Health and Development Field Office
Masaka, Uganda